AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform
Antibody-drug conjugate developer AbTis announced on August 14 that it has prevailed in an inter partes review before the U. S.
Search results for "U.S. patent"
Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003
Rznomics, a biopharmaceutical company specializing in RNA-based gene therapies, announced on the 24th that it has received a decision to grant a U. S.
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation
Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
The Fat-to-Brain Highway: How Aged Garlic Extract Remodels Muscle Health
"If you eat this and do not see sunlight for 100 days, you will become human." According to Korean mythology, those...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.